Adverse Drug Events Reporting News

 

Adverse Drug Events Reporting Perspective

  • Highlights From ASN Kidney Week 2019   Highlights from ASN's Kidney Week 2019 include results from the CREDENCE trial showing benefit from the SGLT2 inhibitor canagliflozin for patients with established diabetic nephropathy.
  • How About a Troubleshooting Guide for Patients? What would serve patients best would be a readily available checklist, says Dr Plotzker.
 

Adverse Drug Events Reporting Journal Articles